| Title | Address | Description |
|---|---|---|
LMU | GESCHWISTER SCHOLL PLATZ 1, 80539 München, |
|
Fundació Clínic per a la Recerca Biomèdica | Carrer del Rosselló, 149, 08036 Barcelona, Spanien |
|
Helmholtz-Zentrum für Infektionsforschung GmbH (HZI) | Ingolstädter Landstraße 1, 85764 Oberschleißheim, Deutschland |
|
Helmholtz Munich | Inhoffenstraße 7, 38124 Braunschweig, Deutschland |  |
Medizinische Hochschule Hannover | Carl-Neuberg-Straße 1, 30625 Hannover, Deutschland |
|
NIMR-Mbeya Medical Research Center | Hospital Hill Rd, Mbeya, Tansania |
|
Technische Universität München | Arcisstraße 21, 80333 München, Deutschland |
|
UNIVERSITY COLLEGE LONDON (UCL) | GOWER STREET, WC1E 6BT London |
|
Klinikum Rechts der Isar der Technischen Universität München | Hörsaal A, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 München, Deutschland |
|
UKE Hamburg Eppendorf | Martinistraße 52, 20251 Hamburg, Deutschland |  |
Azienda Ospedaliero- Universitaria di Parma | Str. dell'Università, 12, 43121 Parma PR, Italien |  |
Universitätsklinikum Leipzig | Ritterstraße 26, 04109 Leipzig, Deutschland |  |
Barts Health NHS Trust | Co-operative Bank Plc, 9 Prescot St, Whitechapel, London E1 8AZ, Vereinigtes Königreich |
|
Royal Free London NHS Foundation Trust | Pond St, Hampstead, London NW3 2QG, Vereinigtes Königreich | |
PNO Innovation GmbH | Oskar-von-Miller-Ring 29, 80333 München, Germany |  |
SocraTec R&D GmbH | Im Setzling 35, 61440 Oberursel (Taunus), Deutschland |  |
Frankfurt University Hospital | Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Deutschland |
|
莱比锡大学
一般信息
莱比锡大学（ULEI）的肝病学系是德国最大的肝病学部门之一。 它包括几个专门的门诊诊所，每年介绍>5,000名患者，涵盖了肝病学，肝癌肿瘤学和肝移植的整个领域，拥有一个由5名全职研究护士和一个研究实验室组成的大型研究办公室。 目前正在或已经进行了从I-IV期开始的临床试验，特别关注乙型肝炎，丙型肝炎，肝细胞癌，脂肪肝疾病（NASH，NAFLD）和其他肝病。
肝病学系的研究实验室进行了大量的临床研究以及基础和转化科学项目，包括病毒性肝炎，肝细胞癌，人类微生物组和肝病基因组学领域。 肝病科已开展了多个国家和国际队列研究。 每年，高排名的出版物都彰显了该部门的强大科学影响力。
莱比锡大学
Klinik und PoliklinikfürOnkologie，胃肠病，肝病，肺炎，Infektiologie
Liebigstr。 20
04103莱比锡
德国
链接
Role in TherVacB
ULEI has long term experience in conducting clinical trials (phase I-IV), appropriate facilities and a well-trained staff. The university is currently involved in several translational studies and has great experience with the collection of patient materials. This includes serum, tissue and circulating blood cell (PBMC) samples, which can be collected and stored according to highest quality requirements. A special focus lies on the development of bio markers for hepatitis B virus infections. The Department of Hepatology has gained significant international reputation in the field and will contribute experience and methodology to the consortium.
ULEI has a large international network with collaborating hospitals and residents and can mobilize significant patient populations for inclusion in the clinical trials. Its experience is especially great in studies in hepatitis B, as well as in vaccine trials.
项目人员
托马斯·伯格
教授兼肝病学系主任
弗洛里安·范·博梅尔
乙型肝炎研究组负责人